Posts Tagged ‘Treatment using Stem cells’
Analysis of Stem Cell Technology
The opportunity for expectant families to collect and store their newborn’s umbilical cord blood stem cells has only been widely available since late 1995. Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity.This Cord Blood can be collected only at birth, and if not taken these stem cells can not be replaced. The opportunity for expectant families to collect and store their newborn’s umbilical cord blood stem cells has only been widely available since late 1995.Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity. Cord blood stem cells are showing significant potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.
In the near future, it will become a common practice to store Cord Blood as future insurance against many diseases.People are storing cord blood as it may offer a lifetime of protection:
- Regenerative medicine therapies using cord blood, the child’s own stem cells are required.
- For treating cancers and blood disorders in transplant medicine, having the family’s own cord blood available has many advantage as it reduces complications.
- The baby’s cord blood may be used to treat many diseases including leukemia, other cancers, and blood disorders.
- Potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.
Some families have more defined risk factors, but most families bank for the security of knowing the health benefits that stem cells may someday offer their children, themselves, or other family members.
Cord Blood America has generated lots of interest in the investing community recently.
As it turns out, the Cord Blood of America been in business (Publicly traded) since 2003 and featured in countless news and media overages, including Fox news.
CBAI, moving toward achieving its goal of becoming a globally dominant stem cell storage company, recently signed a deal licensing its umbilical cord blood technology to AXM Pharma Inc., a China pharmaceutical and nutraceutical company.
They are actually located on Helm Drive in Las Vegas and currently hold the record for the largest cryogenic storage facility in the world. Cryogenic technology deals with materials at low temperatures and the physics of their behavior at these temps.
The principle of cryogenic plants operation is based on the air liquefaction and its subsequent separation with the recovery of nitrogen, oxygen, and argon.
Information from Guide of Cord Blood America